Clinical study identifies factors affecting venous penetration of NBCA during embolization of dural arteriovenous fistulas, suggesting implications for treatment success.
Objective: N-butyl cyanoacrylate (NBCA) must reach the venous side beyond the fistulous point (venous penetration) for the successful transarterial embolization of dural arteriovenous fistulas (DAVFs). The purpose of this study is to identify several factors associated with the venous penetration of NBCA.
No takes yet. Share an insight, caveat, or question.
Matsumoto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: